Log in to save to my catalogue

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from th...

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9635871

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo

About this item

Full title

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2022-11, Vol.40 (50), p.7321-7327

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlight•JYNNEOS vaccination produces robust anti-orthopoxvirus antibody response. •Naive vaccinees generate OPXV-specific IgM early after vaccination. •IgG responses peak around 2 weeks after second vaccine dose. •Titers wane at 2 years, and more rapidly in naïve vaccinees. •Antibodies neutralize VACV and MPXV differently, but had similar rise fr...

Alternative Titles

Full title

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9635871

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9635871

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2022.10.078

How to access this item